Radical retropublc prostatectomy for localized carcinoma of the prostate in a large metropolitan hospital: Changing trends over a 10-year period (1984-1994)

Urology

Volumn 45, Issue 5, 1995, Pages 813-822

  Litwiller, Scott E ^a,b,c   Richier, John C ^a,b,c   Djavan, Babak ^a,b,c   Roehrborn, Claus G ^a,b,c   Klopukh, Boris V ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER LOCALIZATION; CONTROLLED STUDY; FEVER; HUMAN; ILEUS; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; SURGICAL APPROACH; SURGICAL RISK; WOUND INFECTION;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; BLOOD LOSS, SURGICAL; COMORBIDITY; HOSPITALS, COMMUNITY; HOSPITALS, URBAN; HUMAN; INCIDENCE; LENGTH OF STAY; LYMPHATIC METASTASIS; MALE; MIDDLE AGE; NEOPLASM STAGING; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; TEXAS; TIME FACTORS;

EID: 0028828896     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/S0090-4295(99)80089-2     Document Type: Article

References (17)

1. Radical pros tatectomy with preservation of sexual function: anatomical and pathological considerations
2. Measurement of prostate-specific antigen in serum as a screening test for prostate cancer
3. Screening for prostatic carcinoma with prostate-specific antigen
4. Serum prostate specific antigen as pre-screening test for prostate cancer
5. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening
6. Screening for prostate cancer. A decision analytic view
7. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostatic Patient Outcomes Research Team
8. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. Prostate Outcomes Research Team
9. Patient-reported complications and follow-up treatment after radical prostatectomy. The National Medicare Experience: 1988–1990 (Updated June 1993)
10. Cancer control and quality of life following anatomical radical retropubic prostatectomy: results at 10 years
11. Long-term (15 years) results after radical prostatectomy for clinically localized (stage T2c or lower) prostate cancer.
12. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation
13. An assessment of radical prostatectomy. Time trends, geographic variation, and outcomes. The Prostate Patient Re search Team
14. National patterns of prostate cancer treatment by radical prostatectomy: results of survey by American College of Surgeons Commission on Cancer
15. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer
16. Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration
17. Early complications of contemporary anatomical radical retropubic prostatectomy